Drug · DIN 02516764
LEDAGA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 14, 2022; first marketed September 14, 2022.
- Drug Identification Number (DIN)
- 02516764
- Company (DIN owner)
- Recordati Rare Diseases Canada IncToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Gel
- Route
- Topical
- Therapeutic class (ATC)
- Chlormethine L01AA05
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CHLORMETHINE (CHLORMETHINE HYDROCHLORIDE) | 160 MCG | G |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 8, 2021: NOC 26022New Drug Submission (NDS)